Issue 2, 2018

Photoresponsive ruthenium-containing polymers: potential polymeric metallodrugs for anticancer phototherapy

Abstract

This Frontier presents the recent development of photoresponsive Ru-containing polymers for cancer treatment. These novel Ru-containing polymers are prepared by introducing photoresponsive Ru complexes into polymers. Based on their chemical structures in aqueous solutions, these polymers can self-assemble into different nanostructures. The self-assembled nanostructures can circulate in the blood stream, accumulate at tumor tissue, and can be taken up by tumor cells. Red light, which can penetrate into tissue deeply, can induce the photodissociation of these polymers and sensitize singlet oxygen (1O2) generation. Both dissociated Ru complexes and generated 1O2 can inhibit the growth of tumor cells. Photoresponsive Ru-containing polymers provide a new platform for combined photodynamic therapy and photoactivated chemotherapy. The design strategies, self-assembly, photoresponsiveness, and anticancer effects of these polymers are introduced. Some remaining challenges for Ru-containing polymers for phototherapy are discussed.

Graphical abstract: Photoresponsive ruthenium-containing polymers: potential polymeric metallodrugs for anticancer phototherapy

Article information

Article type
Frontier
Submitted
12 Sep 2017
Accepted
15 Nov 2017
First published
16 Nov 2017
This article is Open Access
Creative Commons BY license

Dalton Trans., 2018,47, 283-286

Photoresponsive ruthenium-containing polymers: potential polymeric metallodrugs for anticancer phototherapy

W. Sun, X. Zeng and S. Wu, Dalton Trans., 2018, 47, 283 DOI: 10.1039/C7DT03390G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements